Literature DB >> 29026602

Re-phrasing the question: A simple tool for evaluation of adherence to therapy in patients with inflammatory bowel disease.

T Engel1, B Ungar1, G Ben-Haim1, N Levhar1, R Eliakim1, S Ben-Horin1.   

Abstract

BACKGROUND: Non-adherence to medication in patients with inflammatory bowel disease (IBD) is a challenging problem which is often overlooked or under-estimated by the physician or denied by the patient. We aimed to examine if re-phrasing the wording of the question used by the physician could help in revealing more patients who are non-adherent, and for whom appropriate counseling may be instituted.
METHODS: A cross-sectional questionnaire-based study of IBD patients treated in a tertiary center was conducted. Patients received a questionnaire detailing their treatments and disease course, as well as their perceptions about disease. Two forms of questions about adherence were deliberately placed in two separate parts of the questionnaire: One was 'are you taking your medications regularly as prescribed?' (Standard question), and the second, more emphatic question, was 'how often does it happen that you miss a drug dosing?' (Re-phrased question). The rate of non-adherence disclosed by each of these questions was compared. Sensitivity, specificity and predicative values were computed for each question against the conventional definition of non-adherence as taking of less than 80% of prescribed medication doses disclosed by any of the methods. Predictors of non-compliance and of denying non-compliance were also explored.
RESULTS: Overall, 165 patients were included (49% female, mean age 33.7 ± 12.7 SD, median age 30 years, 29.6% with ulcerative colitis, 62.4% with Crohn's disease). Upon questioning, 50 (30.3%) of the patients admitted to non-adherence in the last month when asked by the emphatic re-phrased question format, compared with only 10 patients (6%) reporting non-adherence when asked directly by the standard question (OR 7.4, 95%CI 3.6-15.2, p < 0.001). Thus, a 'Do you take your medicine regularly' question format disclosed only 20% of genuinely non-compliant patients and had 16% sensitivity and 98.2% specificity for revealing non-adherence (PPV 80%, NPV 72.9%) compared with the reference re-phrased question. The leading cause for non-adherence was skepticism about drug efficacy or safety (20.5%), followed by vacation or weekend (15%), problems with prescription or pharmacy (13.5%) and forgetfulness (10%). No single demographic or clinical factor correlated with non-adherence. The only factor which correlated with higher probability for non-adherence was biological and combination treatment.
CONCLUSION: Non-compliance with treatment is much more common than patients admit. Asking patients how often does it happen that they miss a drug dosing is a simple, practical tool which performs significantly better in disclosing non-adherence compared with asking patients if they take their medication as they should.

Entities:  

Keywords:  Crohn’s disease; Inflammatory bowel disease; adherence; compliance; ulcerative colitis

Year:  2017        PMID: 29026602      PMCID: PMC5625874          DOI: 10.1177/2050640616687838

Source DB:  PubMed          Journal:  United European Gastroenterol J        ISSN: 2050-6406            Impact factor:   4.623


  22 in total

1.  Use of a screening tool to determine nonadherent behavior in inflammatory bowel disease.

Authors:  Sunanda Kane; Brenda Becker; W Scott Harmsen; Ashok Kurian; Donald E Morisky; Alan R Zinsmeister
Journal:  Am J Gastroenterol       Date:  2012-02       Impact factor: 10.864

Review 2.  Treatment Nonadherence in Inflammatory Bowel Disease: Identification, Scope, and Management Strategies.

Authors:  Margot L Herman; Sunanda V Kane
Journal:  Inflamm Bowel Dis       Date:  2015-12       Impact factor: 5.325

3.  Inflammatory bowel disease patients are frequently nonadherent to scheduled induction and maintenance infliximab therapy: A Canadian cohort study.

Authors:  Christopher Ma; Chad J Evaschesen; Grenvil Gracias; Vivian W Huang; Darryl K Fedorak; Karen I Kroeker; Levinus A Dieleman; Brendan P Halloran; Richard N Fedorak
Journal:  Can J Gastroenterol Hepatol       Date:  2015-06-12

Review 4.  Factors associated with non-adherence to oral medication for inflammatory bowel disease: a systematic review.

Authors:  C A Jackson; J Clatworthy; A Robinson; Rob Horne
Journal:  Am J Gastroenterol       Date:  2009-12-08       Impact factor: 10.864

5.  Adherence to medical treatment in inflammatory bowel disease patients.

Authors:  A Zelante; A De Giorgi; R Borgoni; L Trevisani; M Gallerani
Journal:  Minerva Gastroenterol Dietol       Date:  2014-12

6.  Adherence to treatment in inflammatory bowel disease.

Authors:  A López San Román; F Bermejo; E Carrera; M Pérez-Abad; D Boixeda
Journal:  Rev Esp Enferm Dig       Date:  2005-04       Impact factor: 2.086

7.  Patient nonadherence to medication in inflammatory bowel disease.

Authors:  Maida J Sewitch; Michal Abrahamowicz; Alan Barkun; Alain Bitton; Gary E Wild; Albert Cohen; Patricia L Dobkin
Journal:  Am J Gastroenterol       Date:  2003-07       Impact factor: 10.864

8.  Comparison of methods to assess medication adherence and classify nonadherence.

Authors:  Richard A Hansen; Mimi M Kim; Liping Song; Wanzhu Tu; Jingwei Wu; Michael D Murray
Journal:  Ann Pharmacother       Date:  2009-03-03       Impact factor: 3.154

Review 9.  Practical strategies for enhancing adherence to treatment regimen in inflammatory bowel disease.

Authors:  Rachel N Greenley; Jennifer H Kunz; Jennifer Walter; Kevin A Hommel
Journal:  Inflamm Bowel Dis       Date:  2013-06       Impact factor: 5.325

10.  Definitions, variants, and causes of nonadherence with medication: a challenge for tailored interventions.

Authors:  Jacqueline G Hugtenburg; Lonneke Timmers; Petra Jm Elders; Marcia Vervloet; Liset van Dijk
Journal:  Patient Prefer Adherence       Date:  2013-07-10       Impact factor: 2.711

View more
  4 in total

Review 1.  Adherence to r-hGH Therapy in Pediatric Growth Hormone Deficiency: Current Perspectives on How Patient-Generated Data Will Transform r-hGH Treatment Towards Integrated Care.

Authors:  Martin O Savage; Luis Fernandez-Luque; Selina Graham; Paula van Dommelen; Matheus Araujo; Antonio de Arriba; Ekaterina Koledova
Journal:  Patient Prefer Adherence       Date:  2022-07-11       Impact factor: 2.314

2.  Lost in Transition: Pharmacist Roles in Identifying and Evaluating Medication-Related Problems During Hospital Discharge Follow-up Visits in a Primary Care Setting.

Authors:  Alexis Dellogono; Aimee Dawson; Marisa Piers-Gamble; Jerril Varghese; Lori Lewicki
Journal:  J Prim Care Community Health       Date:  2020 Jan-Dec

3.  Pilot Testing Of A Brief Pre-Consultation Screener For Improving The Identification And Discussion Of Medication Adherence In Routine Consultations.

Authors:  John Weinman; Imran Ali; Anna Hodgkinson; Martha Canfield; Christina Jackson
Journal:  Patient Prefer Adherence       Date:  2019-11-05       Impact factor: 2.711

Review 4.  Improving adherence in chronic airways disease: are we doing it wrongly?

Authors:  Gráinne d'Ancona; John Weinman
Journal:  Breathe (Sheff)       Date:  2021-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.